title: Reassessing tumor markers in local recurrences of breast cancer: a new insight.
abstract: BACKGROUND
  It is believed that a local recurrence of a primitive breast cancer has the same prognostic factor profile as its primary breast cancer tumor.
  
  
  METHODS
  We compared the immunohistochemical expressions of the tumor suppressor protein p53, estrogen receptor (ER), c-erbB2, and E-cadherin in 57 primary invasive breast cancers and in their respective LRs. The McNemar test and the kappa index were used for statistical analysis.
  
  
  RESULTS
  In 30 patients (52.6%) the expression of at least one of these markers was different between the primary and locally recurrent tumors. No significant difference was observed between variations in the positive and negative expressions in the primary tumor and local recurrence in cerbB2 (kappa = 0.86), E-cadherin (kappa = 0.55), and p53 (kappa = 0.7). However, the ER presented a low kappa index (kappa = 0.26, p > 0.05).
  
  
  CONCLUSIONS
  ER expression should be reviewed in local recurrent breast cancer. This relevant change in ER expression is likely to change the current clinical practice in breast cancer evaluation and treatment.
authors.affiliation: Unity of Mastology of Hospital Nossa Senhora da Conceição, Ministério da Saide, Brazil. josepedrini@terra.com.br
authors.forename: José Luiz
authors.initials: JL
authors.lastname: Pedrini
authors.forename: Mariana
authors.initials: M
authors.lastname: Pedrini
authors.forename: Ricardo Francalacci
authors.initials: RF
authors.lastname: Savaris
authors.forename: Luciana
authors.initials: L
authors.lastname: Machado
authors.forename: Melina
authors.initials: M
authors.lastname: Grudzinski
authors.forename: Cláudio Galleano
authors.initials: CG
authors.lastname: Zettler
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000473:pathology; D015820:Cadherins / Q000032:analysis; D005260:Female; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis*; D011379:Prognosis; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis; D011960:Receptors, Estrogen / Q000032:analysis; D016159:Tumor Suppressor Protein p53 / Q000032:analysis
chemical_list: D014408:Biomarkers, Tumor; D015820:Cadherins; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D016159:Tumor Suppressor Protein p53